<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health</journal-id><journal-id journal-id-type="iso-abbrev">Environ Health</journal-id><journal-title-group><journal-title>Environmental Health</journal-title></journal-title-group><issn pub-type="epub">1476-069X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24524244</article-id><article-id pub-id-type="pmc">3978125</article-id><article-id pub-id-type="publisher-id">1476-069X-13-8</article-id><article-id pub-id-type="doi">10.1186/1476-069X-13-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Methodology</subject></subj-group></article-categories><title-group><article-title>Pooling samples for &#x0201c;top-down&#x0201d; molecular exposomics research: the methodology</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Shen</surname><given-names>Heqing</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hqshen@iue.ac.cn</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Xu</surname><given-names>Weipan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>wpxu@iue.ac.cn</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Peng</surname><given-names>Siyuan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sypeng@iue.ac.cn</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Scherb</surname><given-names>Hagen</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>scherb@helmholtz-muenchen.de</email></contrib><contrib contrib-type="author" id="A5"><name><surname>She</surname><given-names>Jianwen</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Jianwen.She@cdph.ca.gov</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Voigt</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>kvoigt@helmholtz-muenchen.de</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Alamdar</surname><given-names>Ambreen</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ambreenalamdar@hotmail.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A8"><name><surname>Schramm</surname><given-names>Karl-Werner</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I5">5</xref><email>schramm@helmholtz-muenchen.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, 1799 Jimei Road, Xiamen 361021, PR China</aff><aff id="I2"><label>2</label>Helmholtz Zentrum M&#x000fc;nchen - German Research Center for Environmental Health (GmbH), Institute of Computational Biology, Ingolst&#x000e4;dter Landstr. 1, 85765 Neuherberg, Germany</aff><aff id="I3"><label>3</label>Environmental Health Laboratory Branch, California Department of Public Health, Richmond, CA 94804, USA</aff><aff id="I4"><label>4</label>Helmholtz Zentrum M&#x000fc;nchen - German Research Center for Environmental Health (GmbH), Molecular EXposomics (MEX), Ingolst&#x000e4;dter Landstr. 1, 85764 Neuherberg, Germany</aff><aff id="I5"><label>5</label>Department f&#x000fc;r Biowissenschaftliche Grundlagen, Technische Universit&#x000e4;t M&#x000fc;nchen, Weihenstephaner Steig 23, 85350 Freising, Germany</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>13</day><month>2</month><year>2014</year></pub-date><volume>13</volume><fpage>8</fpage><lpage>8</lpage><history><date date-type="received"><day>17</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Shen et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Shen et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p></license></permissions><self-uri xlink:href="http://www.ehjournal.net/content/13/1/8"/><abstract><sec><title>Background</title><p>Exposomics is the cutting-edge concept of screening the environmental risk factors for disease. In the novel &#x0201c;top-down&#x0201d; approach, we estimate the molecular exposome by measuring all body fluid analytes in a case-controlled study. However, to detect diverse pollutants, a sufficient sample size and multiple analytical methods are required. This may lead to dramatically increased costs and research workload.</p></sec><sec><title>Methods</title><p>To help reduce complexity, we suggest a sample pooling strategy along with a scheme for combining both general unknown or multi-targeted screening with targeted analysis. The sample pooling method was tested using computer simulations.</p></sec><sec><title>Results</title><p>By comprehensively analysis of pooled samples, it is possible to identify environmental risk factors. Factors are initially screened in the pooled case and control population samples, then in the randomized grouped and pooled case and control subpopulation samples. In the sample grouping, five or more pools were suggested for groups having 30 individuals per pool.</p></sec><sec><title>Conclusions</title><p>This study suggests that sample pooling is a useful strategy for exposomics research, which provides a hypothesis-free method for pollutant risk screening.</p></sec></abstract><kwd-group><kwd>Exposome</kwd><kwd>Exposure biomarker</kwd><kwd>Metabolome</kwd><kwd>Effect biomarker</kwd><kwd>Case-control study</kwd><kwd>Environmental pollutants</kwd><kwd>Pooled sample</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>An estimated 70 to 90 percent of risk factors associated with chronic diseases are thought to arise from individuals&#x02019; exposure to environmental hazards [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. This drastic connection raises interest in analyzing ubiquitous environmental risk factors which collectively constitute the &#x0201c;exposome&#x0201d; [<xref ref-type="bibr" rid="B4">4</xref>], a concept first introduced by Wild [<xref ref-type="bibr" rid="B6">6</xref>] and later advocated by Rappaport [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. There is particular interest in analyzing the role of chemical pollutants in epidemiological studies [<xref ref-type="bibr" rid="B5">5</xref>]. Chemical pollutant exposomics thus provides an approach to systematically assess pollutant risk for defined health outcomes in a given population.</p><p>In a so-called &#x0201c;top-down&#x0201d; strategy [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>] all blood analytes including both small endogenous and exogenous molecules can be clustered into one of three groups: environmental chemical pollutants and their metabolic residuals i.e., chemical pollutants&#x02019; exposome, the blood metabolome response to chemical pollutant exposure, and response to other environmental risk factors such as noise, radiation etc. The goal of &#x0201c;top-down&#x0201d; exposomics is to identify biological analytes (i.e., biomarkers) relevant for a defined outcome or disease. Both environmental pollutants and endogenous metabolome need to be considered, although some analytes are sometimes confounded factors in the theory (for example, environmental pollutants and their metabolomic responses in biology).</p><p>The methodology discussed in this study majorly focuses on the broad analysis of environmental pollutants and their metabolites in case-control samples. We propose that the chemical pollutant exposome may be screened in a similar way as in disease-oriented metabolomics analysis [<xref ref-type="bibr" rid="B8">8</xref>]. Furthermore, it may aid in the development of systematic biological models for assessing and illustrating the risk and metabolic impact associated with the exogenous exposome [<xref ref-type="bibr" rid="B9">9</xref>]. Lastly, we show that exposure to arsenic in males is linked to oligozoospermia via analysis of pertinent metabolomic biomarkers [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>Quantitative assessment of the risks associated to pollutant exposure [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>] can be challenging. For instance, molecular epidemiology usually requires large sample numbers in order to verify the hypothesized relationships. Furthermore, bio-monitoring of environmental pollutants is sometimes hampered by their diverse nature in necessitating a set of integrated methods [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. In addition, limited sample volume makes multiple measurements on individual samples difficult or impossible. Considered together, the requirement of large sample size and multiple analyses for each sample proves costly and labor intensive when working with human data. To help overcome these challenges, we propose a sample pooling strategy for molecular exposomics, in which fewer, but larger volume pooled samples are analyzed with the tradeoff losses of the signatures from individual observations in the case-control study.</p><sec><title>Chemical oriented exposomics requires an integrated sample matrix</title><p>Bio-monitoring analysis following chemical exposure is commonly obtained via chemical-oriented targeted measurements. When xenobiotics enter the body, they either accumulate, or are processed metabolically and excreted. Therefore, analytes employed as biomarkers for monitoring could be either parental compounds, their metabolites or their conjugated derivatives with endogenous molecules via enzymatically catalyzed transformations. Generally, non-polar, lipid-soluble forms of chemicals will be metabolized into polar, water-soluble forms and excreted in bile and urine. It is possible to group target pollutants into four families according to various physicochemical properties, as shown in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. These families are:</p><p>1. Persistent organic pollutants (POPs), which tend to accumulate in fatty tissues and redistribute among the other parts of the body via blood as a transport vector. These are usually measured by GC-MS (or HRGC-HRMS) with the exception of some perfluorinated compounds.</p><p>2. Readily degradable compounds, which can readily transform to their metabolites through phase I reactions and further on partly conjugate with endogenous molecules (e.g., glucuronate, sulfate, mercapturic acid ester, acetyl ester, and so on) through phase II reactions to be easily discharged in urine, bile and sweat. These are normally measured using LC-MS techniques.</p><p>3. Accumulated inorganic pollutants, which may be deposited in the kidney (such as cadmium) or bone (such as lead), and which are commonly measured by LC-ICP-MS.</p><p>4. Non-accumulating inorganic pollutants such as arsenic, commonly measured by LC-ICP-MS.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Samples and integration of analytical methods for chemical oriented instrumental measurement</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center"><bold>Sample types</bold></th><th colspan="5" align="center"><bold>Urinary matrix</bold></th><th colspan="4" align="center"><bold>Blood matrix</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom"><bold>Species</bold><hr/></td><td align="center" valign="bottom">Free form<hr/></td><td colspan="4" align="center" valign="bottom">Conjugated form<hr/></td><td colspan="2" align="center" valign="bottom">Protein conjugated form<hr/></td><td colspan="2" align="center" valign="bottom">Free POPs<hr/></td></tr><tr><td align="center" valign="bottom"><bold>Pollutant</bold><hr/></td><td align="center" valign="bottom">Metal or metalloid<hr/></td><td align="center" valign="bottom">Mercapturic acid<hr/></td><td align="center" valign="bottom">Glucuronic acid<hr/></td><td align="center" valign="bottom">Sulfate<hr/></td><td align="center" valign="bottom">Acetyl<hr/></td><td align="center" valign="bottom">Metal or metalloid<hr/></td><td align="center" valign="bottom">HSA-Cys34<hr/></td><td align="center" valign="bottom">Lipophilic POPs<hr/></td><td align="center" valign="bottom">Perfluorinated compounds<hr/></td></tr><tr><td align="center" valign="bottom"><bold>Techniques</bold><hr/></td><td align="center" valign="bottom">ICP-MS<hr/></td><td colspan="4" align="center" valign="bottom">UPLC-HRMS(CNL MS/MS)<hr/></td><td align="center" valign="bottom">ICP-MS<hr/></td><td align="center" valign="bottom">UPLC-HRMS(SRM MS/MS)<hr/></td><td align="center" valign="bottom">GC-SIM-MS<hr/></td><td align="center" valign="bottom">LC-MS/MS<hr/></td></tr><tr><td align="center"><bold>Analysis approach</bold></td><td align="center">1</td><td align="center">2</td><td align="center">3</td><td align="center">4</td><td align="center">5</td><td align="center">6</td><td align="center">7</td><td align="center">8</td><td align="center">9</td></tr></tbody></table><table-wrap-foot><p>CNL: constant neutral loss; GC: gas chromatography; HAS: human serum albumin; POPs: persistent organic pollutants; HRMS: high resolution mass spectrometer; ICP: inductively coupled plasma; MS: mass spectrometer; SIM: Selected ion monitoring; SRM: Selected reaction monitoring; UPLC: ultra performance liquid chromatography.</p></table-wrap-foot></table-wrap><p>Pollutants which are more efficiently metabolized accumulate in urine, and urinary bio-monitoring provides a suitable approach for assessing their internal exposure doses. However, blood samples are still usually preferred for monitoring most persistent pollutants. Although many other types of human samples can be used to ascertain pollutant residues [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], blood and urine are the two most viable due to sampling difficulty, analyte enrichment, and sample preparation complexity arising in the bio-monitoring of other tissue samples types.</p><p>To systematically assess the chemical pollutants exposome, it is necessary to employ a general, untargeted screening analysis. This can be followed by a targeted analysis based on initial findings from the pre-screening. For example, a screening analysis for pollutants could be addressed by using approaches such as adductomics for characterizing electrophilic chemicals [<xref ref-type="bibr" rid="B14">14</xref>], whereas multi-targeted pollutants analysis could run on priority lists suggested by the US EPA [<xref ref-type="bibr" rid="B15">15</xref>] or European Commission [<xref ref-type="bibr" rid="B16">16</xref>]. Since untargeted screening analysis usually has a worse sensitivity than commonly used targeted analysis, it is necessary to utilize pollutant enriched matrices in order to trace environmental contamination levels. Although blood is suitable for the measurement of a diverse range of pollutants [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], pollutant metabolites enriched in urine are usually less abundant than in blood, rendering urine complementary to blood for comprehensive exposome analysis.</p></sec><sec><title>Chemical-orientated exposomics requires an integrated analytical approach</title><p>Complementary techniques are also required for screening the diverse chemicals in urine and blood (Table <xref ref-type="table" rid="T1">1</xref>). Usually, investigations of the chemical exposome are based on the different types of mass spectrometers [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. For targeted and/or untargeted detection of various trace level compounds, high throughput and sensitive mass spectrometry (MS) techniques, such as high resolution MS (HRMS), time-of-flight MS (TOF-MS), and Orbitrap MS have been employed. At present, the coupling of different chromatographic separations by various MS with different ionization techniques provides the most sensitive and specific platform for coping with the wide variety of molecules present in human tissues. For example, in a common configuration, gas chromatography (GC) is used for the separation of thermally stable, volatile and less polar molecules, while liquid chromatography (LC) is used for the separation of thermally labile, non-volatile, more polar chemicals. Lastly, at least three different ionization sources are typically required: electron impact (EI) for volatile or semi-volatile organic pollutants, electrospray ionization (ESI) for readily ionizable water-soluble polar pollutants, and inductively coupled plasma (ICP) for inorganic pollutants.</p><p>To analyze different types of chemicals, multiple analyses of the same samples are also generally required. For instance, POPs such as PCBs and PBDEs can be analyzed by HRGC-HRMS at least 50&#x000a0;&#x003bc;L blood without a complex sample cleanup procedure [<xref ref-type="bibr" rid="B20">20</xref>], whereas, another 50&#x000a0;&#x003bc;L blood might be investigated for perfluorinated compounds by LC-ESI-MS [<xref ref-type="bibr" rid="B21">21</xref>]. One integration scheme for dealing with systemic measurement is proposed in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>. By applying well-developed omics approaches to the task of biomarker mining [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>] it is possible to extricate risk factors from exposome data.</p><p>As discussed earlier, measurements of individual samples in an exposomic study for a large population results not only in an increased analytical workload, but can also rapidly become prohibitively expensive. Additionally, to profile and quantify the chemical exposome in a case-control study, large sample volumes are required from participants (typically blood, urine or both), in order to facilitate multiple measurements. In a typical bio-monitoring study, 2-5&#x000a0;mL of blood and 2-10&#x000a0;mL of spot urine are collected; however such a small sample volume may not be sufficient to screen for all pollutants. Furthermore, collection of larger sample volumes may lead to decreased study participation. The sample pooling strategy suggested in this study is designed to help mitigate these problems.</p></sec><sec><title>Preliminary exposome analysis using pooled population samples</title><p>For disease-oriented exposome analysis, we suggest pooling samples separately for case and control populations. Equal fractions of individual samples are mixed from each population separately, and afterwards qualitative and semi-quantitative screening of the composed samples can be conducted. To adjust for potentially confounding factors such as sex, age or race, we also advocate sample stratification before pooling [<xref ref-type="bibr" rid="B24">24</xref>]. Sample pooling has the advantage that: (1) sample volumes are large enough for multiple measurements, and (2) analytical workload can be greatly reduced. Large sample volumes allow measurements to be repeated 6-10 times, which provides the power to demonstrate statistical significance of the analytical variation of the mean value [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. In addition, large sample volumes are suitable for a wide range of analytes measurement by using the different methodologies.</p><p>However, while pooled samples facilitate the robust analysis of diverse chemical analytes, only population means (<italic>&#x003bc;</italic><sub><italic>case</italic></sub> and <italic>&#x003bc;</italic><sub><italic>control</italic></sub>) are available following such analysis [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B28">28</xref>]. In other words, among the two sources of variation, only the between-measurement analytical variation but the between-subject biological variation is available. So analyte distributions in the case and control samples are forfeited, including the variances of (<italic>&#x003c3;</italic><sup><italic>2</italic></sup><sub><italic>case</italic></sub> and <italic>&#x003c3;</italic><sup><italic>2</italic></sup><sub><italic>control</italic></sub>); therefore, the results compromise the comparison between the case and control [<xref ref-type="bibr" rid="B28">28</xref>]. Although less straight-forward than for unpooled samples, one can nonetheless estimate analytical variation by performing at least 6 repeated measurements the blood or urine samples. Importantly, using pooled samples, it is still possible to compute the populations mean ratio (<italic>&#x003bc;</italic><sub><italic>case</italic></sub> / <italic>&#x003bc;</italic><sub><italic>control</italic></sub>) or fold change (FC) between case and control, a common measure for establishing differences in analyte concentration. Furthermore, as with gene microarray analysis and metabolomics analysis, FCs can be used for establishing the references or cut-offs [<xref ref-type="bibr" rid="B23">23</xref>]. Because pooled samples are based on diseases, the preliminary pollutant screening may directly link the chemicals to their risks.</p></sec><sec><title>Primary exposome analysis using pooled subpopulation samples</title><p>The inter-subpopulation variance analysis of the means of pooled subpopulation samples could augment disease-oriented analyte screening. It stands to reason that if there is a significant difference of an analyte X between case and control populations, there should also be a significant difference in the constitutive subpopulations.</p><p>Randomized grouping the individual samples is the fundamental strategy in the preparation of pooled subpopulation samples. According to the general central limit theorem, irrespective of the true distribution of an analyte X in the population, the means of the sampled subpopulations tend to a normal distribution as the number of sample pools increased to five and above [<xref ref-type="bibr" rid="B27">27</xref>]. Thus, adequate numbers of samples per pool and adequate numbers of sample pools must be taken into consideration during study design [<xref ref-type="bibr" rid="B28">28</xref>]. For example, a population of 300 individuals evenly split into case and control subpopulations can be used to construct 150 case individuals and 150 control samples using 30 samples per pool. In any case, subpopulations are assumed to exhibit the same distribution patterns as the unpooled populations. The means of the pooled samples (i.e., <inline-formula><mml:math id="M1" name="1476-069X-13-8-i1" overflow="scroll"><mml:msub><mml:mover accent="true"><mml:mi mathvariant="italic">x</mml:mi><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover><mml:mrow><mml:mi mathvariant="italic">case</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M2" name="1476-069X-13-8-i2" overflow="scroll"><mml:msub><mml:mover accent="true"><mml:mi mathvariant="italic">x</mml:mi><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover><mml:mrow><mml:mi mathvariant="italic">control</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>; where <italic>k</italic> is the pool number) and the inter-subpopulation variances (i.e., <inline-formula><mml:math id="M3" name="1476-069X-13-8-i3" overflow="scroll"><mml:msubsup><mml:mi mathvariant="italic">s</mml:mi><mml:mrow><mml:mi mathvariant="italic">subp</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">case</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></inline-formula> and <inline-formula><mml:math id="M4" name="1476-069X-13-8-i4" overflow="scroll"><mml:msubsup><mml:mi mathvariant="italic">s</mml:mi><mml:mrow><mml:mi mathvariant="italic">subp</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="italic">control</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></inline-formula>) can be calculated by using formula (1). The pooled case and control sample means are normallz distributed, and the hypothesis of differing sample mean can be tested by using the t-Test.</p><p><disp-formula id="bmcM1"><label>(1)</label><mml:math id="M5" name="1476-069X-13-8-i5" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi mathvariant="italic">s</mml:mi><mml:mi mathvariant="italic">subp</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi mathvariant="italic">k</mml:mi></mml:mfrac><mml:mstyle displaystyle="true"><mml:munderover accentunder="true"><mml:mi mathsize="big">&#x02211;</mml:mi><mml:mrow><mml:mi mathvariant="italic">i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant="italic">k</mml:mi></mml:munderover></mml:mstyle><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mover accent="true"><mml:msub><mml:mi mathvariant="italic">x</mml:mi><mml:mi mathvariant="italic">i</mml:mi></mml:msub><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover><mml:mo>-</mml:mo><mml:mi mathvariant="italic">&#x003bc;</mml:mi></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></disp-formula></p><p>Since subpopulations&#x02019; means and their inter-subpopulation variances can be measured in a cost-efficient manner, the sample pooling technique has been proposed for contaminant biomonitoring [<xref ref-type="bibr" rid="B26">26</xref>]. Although statistically significant differences in sample means between case and control can be calculated using pooled samples, statistical sensitivity to detect differences may still decrease without individual variations. Therefore, pooled data have as a tradeoff lower sensitivity compared to individual data. However, if the numbers of pools are increased, the sensitivity of case-control differences calculated using subpopulation means would increase to the sensitivity calculated using individual data. Ultimately, it is a matter of finding an adequate balance between the number of sample pools and the required precision. To investigate this interdependency more thoroughly, we conducted simulations using data derived from a mathematic model (artificial data), and also applied the methods to data obtained from the measurement of urinary arsenic.</p></sec><sec><title>Simulation sample pooling strategy for case-control comparison artificial data</title><p>In order to assess sensitivities, 200 data points each for case and control were generated using either normal or log-normal distributions, according to formulae F2-1, F2-2, F3-1, F3-2, for control normal, case normal, control log-normal, and case log-normal, respectively:</p><p><disp-formula><mml:math id="M6" name="1476-069X-13-8-i6" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="italic">x</mml:mi><mml:mi mathvariant="italic">control</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>5</mml:mn><mml:mi mathvariant="italic">r</mml:mi><mml:mspace width="0.2em"/><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mn>2</mml:mn><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>;</mml:mo><mml:mspace width="1em"/><mml:msub><mml:mi mathvariant="italic">x</mml:mi><mml:mi mathvariant="italic">case</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="italic">m</mml:mi><mml:mo>*</mml:mo><mml:mn>5</mml:mn><mml:mi mathvariant="italic">r</mml:mi><mml:mspace width="0.2em"/><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mn>2</mml:mn><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math></disp-formula></p><p><disp-formula><mml:math id="M7" name="1476-069X-13-8-i7" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="italic">x</mml:mi><mml:mi mathvariant="italic">control</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi mathvariant="italic">e</mml:mi><mml:mrow><mml:mn>5</mml:mn><mml:mi mathvariant="italic">r</mml:mi></mml:mrow></mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mn>3</mml:mn><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>;</mml:mo><mml:mspace width="1em"/><mml:msub><mml:mi mathvariant="italic">x</mml:mi><mml:mi mathvariant="italic">case</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="italic">m</mml:mi><mml:msup><mml:mi mathvariant="italic">e</mml:mi><mml:mrow><mml:mn>5</mml:mn><mml:mi mathvariant="italic">r</mml:mi></mml:mrow></mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mn>3</mml:mn><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math></disp-formula></p><p>In the simulation models, <italic>r</italic> is a random number between 0 and 1, and <italic>m</italic> is the fold-change between control and case. Although <italic>m</italic> was set to the values 1, 1.5, 2, 3 and 6, the separately random generating of <italic>x</italic><sub><italic>control</italic></sub> and <italic>x</italic><sub><italic>case</italic></sub> resulted in the modifications. <italic>m</italic>&#x02009;=&#x02009;1.0, 1.4, 1.9, 2.9 and 5.6 in the normal distributions (Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>), whereas <italic>m</italic>&#x02009;=&#x02009;1.1, 1.6, 2.3, 4.9 and 6.8 in the log-normal distributions (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>), respectively. Using these generated data, the case-control differences were then tested using the pooled sample means (t-Test with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 is set for significance), where the numbers of pools were set to 2, 3, 4, and 5 (coded as G2, G3, G4 and G5 in Figures&#x000a0;<xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>). By performing 100 random regroupings of the two populations, we show that by increasing the number of pools, the frequency of non-significant differences between case and control subpopulations decreases for simulated data with a true difference between case and control (i.e., the set means of the case are <italic>m</italic>&#x02009;=&#x02009;5.6, 2.9, 1.9 and 1.4-folds of the control in Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref> with codes D1, D2, D3 and D4, respectively; the set means of the case are <italic>m</italic>&#x02009;=&#x02009;6.8, 4.9, 2.3 and 1.6-folds of the control in Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref> with codes D1, D2, D3 and D4, respectively). As a result, we conclude that for the normally distributed populations, three or more pooled samples are enough to detect the case-control differences (Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>). However, for the log-normally distributed data, a minimum of four sets of pools are required (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>) because the increased number of pools caused their means to be more normally distributed [<xref ref-type="bibr" rid="B27">27</xref>]. From the simulated data we conclude that the detection of case-control differences depends on both the difference in the population means, and the number of pools.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>When the random grouping numbers of pools risen to three, the frequency of non-significant difference between the case and control data with normal distributions reached down to the value of that the difference calculated by individual data*.</bold> The pool numbers (i.e., numbers of pools in x-axis) was set as 2, 3, 4, and 5 and coded as G2, G3, G4, and G5; 100 times random grouping was applied to the 200 artificial data with normal distributions for the case and control populations, respectively; the means of the case are 1.0, 1.4, 1.9, 2.9 and 5.6-folds of the control and coded as D5, D4, D3, D2 and D1, respectively. *For the upper mentioned normal distribution data, calculated differences by using three random pool means of the case and control, respectively, should be the same as by using the individual data.</p></caption><graphic xlink:href="1476-069X-13-8-1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>When the random grouping numbers of pools risen to five, the frequency of non-significant difference between the case and control data with log-normal distributions reached down to the value of that the difference calculated by individual data*.</bold> The pool numbers (i.e., numbers of pools in x-axis) was set as 2, 3, 4, and 5 and coded as G2, G3, G4, and G5; 100 times random grouping was applied to the 200 artificial data with log-normal distributions for the case and control populations, respectively; the means of the case are 1.1, 1.6, 2.3, 4.9 and 6.8-folds of the control; the means of the case are 1.1, 1.6, 2.3, 4.9 and 6.8-folds of the control and coded as D5, D4, D3, D2 and D1, respectively. *For the upper mentioned log-normal distribution data, calculated differences by using five random pool means of the case and control, respectively, should be close to by using the individual data.</p></caption><graphic xlink:href="1476-069X-13-8-2"/></fig></sec><sec><title>Simulation sample pooling strategy for case-control comparison: measured data</title><p>Measured urinary analyte data are often adjusted for creatinine. Accordingly, volume of individual samples used to constitute the sample pool should also be adjusted according to creatinine concentrations. The sample sizes of case-1, case-2 and control are 157, 140 and 151, respectively. Here the case-1 samples consist of urine from subjects with definite idiopathic male infertility and normal semen parameters (unpublished data), the case-2 samples consists of urine from definite idiopathic subjects with male infertility and oligospermia [<xref ref-type="bibr" rid="B10">10</xref>] and the control samples of urine from healthy males with normal reproductive function [<xref ref-type="bibr" rid="B10">10</xref>]. The measured arsenic species are dimethylarsinic acid (DMA), arsenite (As<sup>III</sup>), methylarsonic acid (MMA), arsenobetaine (AsB) and arsenate (As<sup>V</sup>). Case-1 (CC1 in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>) showed FC values of 1.0, 1.1, 1.4, 1.5 and 3.7 compared to control, whereas case-2 (CC2 in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>) showed FC values of 1.2, 1.3, 1.2, 1.5 and 3.2 for the analyte DMA, As<sup>III</sup>, MMA, AsB and As<sup>V</sup>, respectively. Statistical analysis showed that the FC versus control calculated by individual observations for As<sup>III</sup> in case-1, for As<sup>III</sup>, MMA and AsB in case-2 were not robust (i.e. different results were obtained by Welch t-Test and K-S Test), when FC values were&#x02009;&#x02264;&#x02009;1.5. However, in some situations, the differences are robust even for FC values close to 1 (DMA in CC1), which may suggest an important role for variance and distribution information in the statistics [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Moreover, further analysis showed that the dose-dependent adjusted odds ratio trends (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>) were only significant for total arsenic along with As<sup>V</sup> in CC1 (unpublished data) and CC2 [<xref ref-type="bibr" rid="B10">10</xref>].</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Descriptive statistics of arsenic species in the case-1, -2, and control subjects:</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center" valign="bottom">&#x000a0;<hr/></th><th colspan="4" align="center" valign="bottom"><bold>Arsenic in case-1 (n=157)</bold><hr/></th><th colspan="4" align="center" valign="bottom"><bold>Arsenic in case-2 (n=140)</bold><hr/></th><th colspan="4" align="center" valign="bottom"><bold>Arsenic in control (n=151)</bold><hr/></th><th colspan="2" align="center" valign="bottom"><bold>Fold change</bold><hr/></th><th colspan="2" align="center" valign="bottom"><bold>Welch t-Testt-Testt-Test</bold><hr/></th><th colspan="2" align="center" valign="bottom"><bold>K-S Test</bold><hr/></th><th colspan="2" align="center" valign="bottom"><bold>Dose-trend</bold><hr/></th></tr><tr><th align="center">&#x000a0;</th><th align="center"><bold>Mean</bold></th><th align="center"><bold>SD</bold></th><th align="center"><bold>GM</bold></th><th align="center"><bold>Median</bold></th><th align="center"><bold>Mean</bold></th><th align="center"><bold>SD</bold></th><th align="center"><bold>GM</bold></th><th align="center"><bold>Median</bold></th><th align="center"><bold>Mean</bold></th><th align="center"><bold>SD</bold></th><th align="center"><bold>GM</bold></th><th align="center"><bold>Median</bold></th><th align="center"><bold>CC1</bold></th><th align="center"><bold>CC2</bold></th><th align="center"><bold>CC1</bold></th><th align="center"><bold>CC2</bold></th><th align="center"><bold>CC1</bold></th><th align="center"><bold>CC2</bold></th><th align="center"><bold>CC1</bold></th><th align="center"><bold>CC2</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom"><bold>Total Arsenic</bold><hr/></td><td align="center" valign="bottom">246.9<hr/></td><td align="center" valign="bottom">326.2<hr/></td><td align="center" valign="bottom">124.4<hr/></td><td align="center" valign="bottom">140.4<hr/></td><td align="center" valign="bottom">214.1<hr/></td><td align="center" valign="bottom">355.6<hr/></td><td align="center" valign="bottom">96.0<hr/></td><td align="center" valign="bottom">91.4<hr/></td><td align="center" valign="bottom">92.1<hr/></td><td align="center" valign="bottom">172.5<hr/></td><td align="center" valign="bottom">49.6<hr/></td><td align="center" valign="bottom">39.3<hr/></td><td align="center" valign="bottom">2.7<hr/></td><td align="center" valign="bottom">2.3<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">Yes<hr/></td><td align="center" valign="bottom">Yes<hr/></td></tr><tr><td align="center" valign="bottom"><bold>AsB</bold><hr/></td><td align="center" valign="bottom">17.5<hr/></td><td align="center" valign="bottom">29.1<hr/></td><td align="center" valign="bottom">10.5<hr/></td><td align="center" valign="bottom">11.6<hr/></td><td align="center" valign="bottom">17.2<hr/></td><td align="center" valign="bottom">44.6<hr/></td><td align="center" valign="bottom">9.8<hr/></td><td align="center" valign="bottom">9.7<hr/></td><td align="center" valign="bottom">11.4<hr/></td><td align="center" valign="bottom">16.9<hr/></td><td align="center" valign="bottom">8.1<hr/></td><td align="center" valign="bottom">7.9<hr/></td><td align="center" valign="bottom">1.5<hr/></td><td align="center" valign="bottom">1.5<hr/></td><td align="center" valign="bottom">0.026<hr/></td><td align="center" valign="bottom">0.151<hr/></td><td align="center" valign="bottom">0.002<hr/></td><td align="center" valign="bottom">0.004<hr/></td><td align="center" valign="bottom">No<hr/></td><td align="center" valign="bottom">No<hr/></td></tr><tr><td align="center" valign="bottom"><bold>Arsenite(As</bold><sup>
<bold>III</bold>
</sup><bold>)</bold><hr/></td><td align="center" valign="bottom">4.9<hr/></td><td align="center" valign="bottom">4.1<hr/></td><td align="center" valign="bottom">3.0<hr/></td><td align="center" valign="bottom">4.1<hr/></td><td align="center" valign="bottom">5.7<hr/></td><td align="center" valign="bottom">7.9<hr/></td><td align="center" valign="bottom">3.5<hr/></td><td align="center" valign="bottom">4.1<hr/></td><td align="center" valign="bottom">4.4<hr/></td><td align="center" valign="bottom">3.1<hr/></td><td align="center" valign="bottom">3.4<hr/></td><td align="center" valign="bottom">3.9<hr/></td><td align="center" valign="bottom">1.1<hr/></td><td align="center" valign="bottom">1.3<hr/></td><td align="center" valign="bottom">0.270<hr/></td><td align="center" valign="bottom">0.066<hr/></td><td align="center" valign="bottom">0.034<hr/></td><td align="center" valign="bottom">0.046<hr/></td><td align="center" valign="bottom">No<hr/></td><td align="center" valign="bottom">No<hr/></td></tr><tr><td align="center" valign="bottom"><bold>Arsenate(As</bold><sup>
<bold>V</bold>
</sup><bold>)</bold><hr/></td><td align="center" valign="bottom">184.9<hr/></td><td align="center" valign="bottom">309.6<hr/></td><td align="center" valign="bottom">44.3<hr/></td><td align="center" valign="bottom">73.3<hr/></td><td align="center" valign="bottom">159.8<hr/></td><td align="center" valign="bottom">343.3<hr/></td><td align="center" valign="bottom">19.6<hr/></td><td align="center" valign="bottom">28.0<hr/></td><td align="center" valign="bottom">50.0<hr/></td><td align="center" valign="bottom">165.0<hr/></td><td align="center" valign="bottom">2.4<hr/></td><td align="center" valign="bottom">1.8<hr/></td><td align="center" valign="bottom">3.7<hr/></td><td align="center" valign="bottom">3.2<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.001<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">Yes<hr/></td><td align="center" valign="bottom">Yes<hr/></td></tr><tr><td align="center" valign="bottom"><bold>DMA</bold><hr/></td><td align="center" valign="bottom">23.3<hr/></td><td align="center" valign="bottom">15.9<hr/></td><td align="center" valign="bottom">18.7<hr/></td><td align="center" valign="bottom">19.1<hr/></td><td align="center" valign="bottom">27.1<hr/></td><td align="center" valign="bottom">21.3<hr/></td><td align="center" valign="bottom">20.5<hr/></td><td align="center" valign="bottom">23.4<hr/></td><td align="center" valign="bottom">22.7<hr/></td><td align="center" valign="bottom">15.4<hr/></td><td align="center" valign="bottom">18.2<hr/></td><td align="center" valign="bottom">19.1<hr/></td><td align="center" valign="bottom">1.0<hr/></td><td align="center" valign="bottom">1.2<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.044<hr/></td><td align="center" valign="bottom">0.000<hr/></td><td align="center" valign="bottom">0.009<hr/></td><td align="center" valign="bottom">No<hr/></td><td align="center" valign="bottom">No<hr/></td></tr><tr><td align="center"><bold>MMA</bold></td><td align="center">4.9</td><td align="center">4.1</td><td align="center">3.4</td><td align="center">3.9</td><td align="center">4.2</td><td align="center">3.4</td><td align="center">3.1</td><td align="center">3.3</td><td align="center">3.5</td><td align="center">2.5</td><td align="center">2.8</td><td align="center">2.8</td><td align="center">1.4</td><td align="center">1.2</td><td align="center">0.001</td><td align="center">0.073</td><td align="center">0.001</td><td align="center">0.162</td><td align="center">No</td><td align="center">No</td></tr></tbody></table><table-wrap-foot><p>The case-1, case-2 and control have included the individual samples 157, 140 and 151 in respectively; Welch t-Test: <italic>p</italic>-Value of Welch Modified Two-Sample t-Test; K-S Test: Two-Sample Kolmogorov-Smirnov Test; Dose trend: at least one of the quartiles (the 4<sup>th</sup> quartile for the monotonic trend) has adjusted odds ratios are significant and the trend analys is &#x000a0;<italic>p</italic>&#x02009;&#x02264;&#x02009;0.000&#x000a0;(<italic>&#x003c7;</italic><sup>2</sup>&#x02009;-&#x02009;Test); SD: standard deviation; GM: geometric mean; CC1: control-case-1; CC2: control-case-2.</p></table-wrap-foot></table-wrap><p>In the present study, simulation was also applied to actual measured arsenic data as previously described. We found that with 100 random groupings of cases and controls, the frequency of non-significant differences between case and control are still high (around 20%) for the ternary groups of the species with FCs &#x02265;2 (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref> and Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>). For As<sup>V</sup>, MMA (case-1 only), and total arsenic (Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>), the pooled sample means show significant difference between case and control, especially when individuals are grouped four or five times. We therefore conclude that pooled subpopulation samples are sufficient to reveal differences between case and control (Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>When the random grouping numbers of pools risen to eight, the expected frequency of non-significant difference between the case and control for some arsenic species reached down to the value of that the difference calculated by individual data*.</bold> The pool numbers (i.e., numbers of pools in x-axis) was set as 2, 3, 4, 5 and 8 and coded as G2, G3, G4, G5 and G8; n&#x02009;=&#x02009;157, 140, and 151 for the case-1, case-2 and control subjects (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>); 100 times random grouping was applied to the populations; As<sup>V</sup>: arsenate; As: the total arsenic; MMA: methylarsonic acid; As<sup>III</sup>: arsenite; DMA: dimethylarsinic acid; AsB: arsenobetaine. *For the upper mentioned bio-monitoring data can not be normalized by logarithmic transformation, calculated differences by using &#x0003e;5 random pool means of the case and control, respectively, may be close to by using the individual data.</p></caption><graphic xlink:href="1476-069X-13-8-3"/></fig><p>In contrast to the artificial log-normally distributed data (Figures&#x000a0;<xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>), pooled subpopulation means are not sensitive enough to recognize minor, but significant differences between case and control for arsenic for FC &#x02264;1.5 (Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>). This may be because the data distributions are not exactly log-normal in most situations. However, even if only the subpopulation means are measured, they are still sensitive enough to reveal health risk factors, as shown for As<sup>V</sup> and total arsenic with FC&#x02009;&#x02265;&#x02009;2, which have been linked to the male infertility risk in a dose-dependent manner [<xref ref-type="bibr" rid="B10">10</xref>].</p></sec><sec><title>Schematic methodology for exposome analysis</title><p>The screened analytes from pooled samples may be further analyzed by utilizing individual samples. However, the volume of individual samples is usually insufficient for broad-spectrum analysis of all pollutants. Instead it is usually necessary to restrict the analysis to one specific class of pollutant in one specific subgroup of samples. For example, urine samples from 30 individual observations can be used for mercapturic acid conjugated pollutant analysis in one subgroup whereas another subgroup can be used to screen for heavy metals (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). Following random selection of the subgroup samples, the statistical parameters of their parental populations can be estimated as well. Finally, we present a methodology workflow (Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>) from the pooled sample untargeted screening, to the subgroup individual sample targeted analysis for the molecular exposomein a designed case-control. This method is well suited to meet the challenges presented by exposomics research [<xref ref-type="bibr" rid="B29">29</xref>].</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Combing the untargeted and targeted analysis: a scheme for panoramic assessment of the environmental pollutants&#x02019; risks in a defined case-control population.</p></caption><graphic xlink:href="1476-069X-13-8-4"/></fig></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In a traditional molecular epidemiology study (i.e., case-control design), monitoring of individual samples without pooling may prove a sufficient approach. However, in molecular exposomics, a broad-spectrum strategy for hypothesis-free pollutant risk screening, sample pooling is a valuable tool for reducing costs, workload and the need for large individual sample volumes. In this context, the present methodology provides a viable alternative, starting with screening analysis in pooled population samples, followed by randomized grouping of subpopulation samples. Although it has some disadvantages, such as the loss of individual information, it is nonetheless a useful tool. We suggest that approximately five pools and 30 samples per pool from the case and control populations may be sufficient to investigate the disease risk of chemical pollution. However, more sample pools and more samples per pool will always lead to higher quality research.</p></sec><sec><title>Competing interests</title><p>The authors declare no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>HS and KWS conceived the study; WX measured the urinary arsenic data. HS wrote the draft and SP, HS, JS, KV, AA and KWS helped finish it. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgement</title><p>We are grateful to Justin Feigelman for help with the style and language of our paper. This work was financially supported by the Chinese Academy of Sciences (CAS) Hundred Talent Program 2010 for Human Exposure to Environmental Pollutant and Health Effect, NSFC 2011 research foundation (21177123), the CAS/SAFEA International Partnership Program for Creative Research Teams (KZCX2-YW-T08).</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Holm</surname><given-names>NV</given-names></name><name><surname>Verkasalo</surname><given-names>PK</given-names></name><name><surname>Iliadou</surname><given-names>A</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Skytthe</surname><given-names>A</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name><article-title>Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><issue>2</issue><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1056/NEJM200007133430201</pub-id><pub-id pub-id-type="pmid">10891514</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Hindorff</surname><given-names>LA</given-names></name><name><surname>Sethupathy</surname><given-names>P</given-names></name><name><surname>Junkins</surname><given-names>HA</given-names></name><name><surname>Ramos</surname><given-names>EM</given-names></name><name><surname>Mehta</surname><given-names>JP</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Manolio</surname><given-names>TA</given-names></name><article-title>Potential etiologic and functional implications of genome-wide association loci for human diseases and traits</article-title><source>Proc Natl Acad Sci</source><year>2009</year><volume>106</volume><issue>23</issue><fpage>9362</fpage><lpage>9367</lpage><pub-id pub-id-type="doi">10.1073/pnas.0903103106</pub-id><pub-id pub-id-type="pmid">19474294</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Willett</surname><given-names>WC</given-names></name><article-title>Balancing life-style and genomics research for disease prevention</article-title><source>Science</source><year>2002</year><volume>296</volume><issue>5568</issue><fpage>695</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1126/science.1071055</pub-id><pub-id pub-id-type="pmid">11976443</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Rappaport</surname><given-names>SM</given-names></name><article-title>Implications of the exposome for exposure science</article-title><source>J Expo Sci Environ Epidemiol</source><year>2011</year><volume>21</volume><issue>1</issue><fpage>5</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/jes.2010.50</pub-id><pub-id pub-id-type="pmid">21081972</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Callaway</surname><given-names>E</given-names></name><article-title>Daily dose of toxics to be tracked</article-title><source>Nature</source><year>2012</year><volume>491</volume><issue>7426</issue><fpage>647</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1038/491647a</pub-id><pub-id pub-id-type="pmid">23192121</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Wild</surname><given-names>CP</given-names></name><article-title>Complementing the genome with an &#x0201c;exposome&#x0201d;: the outstanding challenge of environmental exposure measurement in molecular epidemiology</article-title><source>Canc Epidemiol Biomarkers Prev</source><year>2005</year><volume>14</volume><issue>8</issue><fpage>1847</fpage><lpage>1850</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0456</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Rappaport</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>MT</given-names></name><article-title>Environment and disease risks</article-title><source>Science</source><year>2010</year><volume>330</volume><issue>6003</issue><fpage>460</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1126/science.1192603</pub-id><pub-id pub-id-type="pmid">20966241</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>She</surname><given-names>J</given-names></name><name><surname>Tolstikov</surname><given-names>VV</given-names></name><article-title>A comprehensive workflow of mass spectrometry-based untargeted metabolomics in cancer metabolic biomarker discovery using human plasma and urine</article-title><source>Metabolites</source><year>2013</year><volume>3</volume><issue>3</issue><fpage>787</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.3390/metabo3030787</pub-id><pub-id pub-id-type="pmid">24958150</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Krysiak&#x02012;Baltyn</surname><given-names>K</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name><name><surname>Skakkebaek</surname><given-names>N</given-names></name><name><surname>Jensen</surname><given-names>TS</given-names></name><name><surname>Virtanen</surname><given-names>H</given-names></name><name><surname>Schramm</surname><given-names>KW</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Vartiainen</surname><given-names>T</given-names></name><name><surname>Kiviranta</surname><given-names>H</given-names></name><name><surname>Taboureau</surname><given-names>O</given-names></name><article-title>Association between chemical pattern in breast milk and congenital cryptorchidism: modelling of complex human exposures</article-title><source>Int J Androl</source><year>2012</year><volume>35</volume><issue>3</issue><fpage>294</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2605.2012.01268.x</pub-id><pub-id pub-id-type="pmid">22519522</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>FL</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><article-title>Urinary metabolic biomarkers link oxidative stress indicators associated with general arsenic exposure to male infertility in a Han Chinese population</article-title><source>Environ Sci Tech</source><year>2013</year><volume>47</volume><fpage>8843</fpage><lpage>8851</lpage></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="other"><name><surname>Schramm</surname><given-names>K-W</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Temoka</surname><given-names>C</given-names></name><name><surname>Pfister</surname><given-names>G</given-names></name><name><surname>Henkelmann</surname><given-names>B</given-names></name><name><surname>Scherb</surname><given-names>H</given-names></name><article-title>Chemical-and effect-oriented exposomics: Three Gorges Reservoir (TGR)</article-title><source>Environ Sci Pollut Res</source><year>2012</year><fpage>1</fpage><lpage>6</lpage></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Barr</surname><given-names>DB</given-names></name><name><surname>Wang</surname><given-names>RY</given-names></name><name><surname>Needham</surname><given-names>LL</given-names></name><article-title>Biologic monitoring of exposure to environmental chemicals throughout the life stages: requirements and issues for consideration for the National Children&#x02019;s Study</article-title><source>Environ Health Perspect</source><year>2005</year><volume>113</volume><issue>8</issue><fpage>1083</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1289/ehp.7617</pub-id><pub-id pub-id-type="pmid">16079083</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Smolders</surname><given-names>R</given-names></name><name><surname>Schramm</surname><given-names>K-W</given-names></name><name><surname>Stenius</surname><given-names>U</given-names></name><name><surname>Grellier</surname><given-names>J</given-names></name><name><surname>Kahn</surname><given-names>A</given-names></name><name><surname>Trnovec</surname><given-names>T</given-names></name><name><surname>Sram</surname><given-names>R</given-names></name><name><surname>Schoeters</surname><given-names>G</given-names></name><article-title>A review on the practical application of human biomonitoring in integrated environmental health impact assessment</article-title><source>J Toxicol Environ Health B</source><year>2009</year><volume>12</volume><issue>2</issue><fpage>107</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1080/15287390802706397</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Rappaport</surname><given-names>SM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Grigoryan</surname><given-names>H</given-names></name><name><surname>Funk</surname><given-names>WE</given-names></name><name><surname>Williams</surname><given-names>ER</given-names></name><article-title>Adductomics: characterizing exposures to reactive electrophiles</article-title><source>Toxicol Lett</source><year>2012</year><volume>213</volume><issue>1</issue><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2011.04.002</pub-id><pub-id pub-id-type="pmid">21501670</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="other"><article-title>Priority pollutants</article-title><comment><ext-link ext-link-type="uri" xlink:href="http://water.epa.gov/scitech/methods/cwa/pollutants.cfm">http://water.epa.gov/scitech/methods/cwa/pollutants.cfm</ext-link></comment></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="other"><article-title>Endocrine disruptors</article-title><comment><ext-link ext-link-type="uri" xlink:href="http://ec.europa.eu/environment/chemicals/endocrine/index_en.htm">http://ec.europa.eu/environment/chemicals/endocrine/index_en.htm</ext-link></comment></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Mounicou</surname><given-names>S</given-names></name><name><surname>Szpunar</surname><given-names>J</given-names></name><name><surname>Lobinski</surname><given-names>R</given-names></name><article-title>Metallomics: the concept and methodology</article-title><source>Chem Soc Rev</source><year>2009</year><volume>38</volume><issue>4</issue><fpage>1119</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1039/b713633c</pub-id><pub-id pub-id-type="pmid">19421584</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Rubino</surname><given-names>FM</given-names></name><name><surname>Pitton</surname><given-names>M</given-names></name><name><surname>Di Fabio</surname><given-names>D</given-names></name><name><surname>Colombi</surname><given-names>A</given-names></name><article-title>Toward an &#x0201c;omic&#x0201d; physiopathology of reactive chemicals: thirty years of mass spectrometric study of the protein adducts with endogenous and xenobiotic compounds</article-title><source>Mass Spectrom Rev</source><year>2009</year><volume>28</volume><issue>5</issue><fpage>725</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1002/mas.20207</pub-id><pub-id pub-id-type="pmid">19127566</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Liebler</surname><given-names>DC</given-names></name><article-title>Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures</article-title><source>Environ Health Perspect</source><year>2002</year><volume>110</volume><issue>Suppl 1</issue><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11834459</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Ip</surname><given-names>HSS</given-names></name><name><surname>Barley</surname><given-names>F</given-names></name><name><surname>Ramage</surname><given-names>R</given-names></name><name><surname>She</surname><given-names>J</given-names></name><article-title>Measurements of polybrominated diphenyl ethers and polychlorinated biphenyls in a single drop of blood</article-title><source>J Chromatogr B</source><year>2012</year><volume>891</volume><fpage>36</fpage><lpage>43</lpage></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Kannan</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Bell</surname><given-names>EM</given-names></name><name><surname>Druschel</surname><given-names>CM</given-names></name><name><surname>Caggana</surname><given-names>M</given-names></name><name><surname>Aldous</surname><given-names>KM</given-names></name><article-title>Analysis of polyfluoroalkyl substances and bisphenol A in dried blood spots by liquid chromatography tandem mass spectrometry</article-title><source>Anal Bioanal Chem</source><year>2013</year><volume>405</volume><issue>12</issue><fpage>4127</fpage><lpage>4138</lpage><pub-id pub-id-type="doi">10.1007/s00216-013-6787-3</pub-id><pub-id pub-id-type="pmid">23404131</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Nicholson</surname><given-names>JK</given-names></name><name><surname>Lindon</surname><given-names>JC</given-names></name><name><surname>Holmes</surname><given-names>E</given-names></name><article-title>&#x02018;Metabonomics&#x02019;: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data</article-title><source>Xenobiotica</source><year>1999</year><volume>29</volume><issue>11</issue><fpage>1181</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1080/004982599238047</pub-id><pub-id pub-id-type="pmid">10598751</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><article-title>An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid</article-title><source>J Pharm Biomed Anal</source><year>2013</year><volume>86</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">23978341</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Grigoryan</surname><given-names>H</given-names></name><name><surname>Funk</surname><given-names>WE</given-names></name><name><surname>Lu</surname><given-names>SS</given-names></name><name><surname>Rose</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>ER</given-names></name><name><surname>Rappaport</surname><given-names>SM</given-names></name><article-title>Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring</article-title><source>Mol Cell Proteomics</source><year>2011</year><volume>10</volume><issue>3</issue><fpage>M110.004606</fpage><comment>doi:10.1074/mcp.M110.004606</comment><pub-id pub-id-type="doi">10.1074/mcp.M110.004606</pub-id><pub-id pub-id-type="pmid">21193536</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Wahrendorf</surname><given-names>J</given-names></name><name><surname>Hanck</surname><given-names>A</given-names></name><name><surname>Munoz</surname><given-names>N</given-names></name><name><surname>Vuilleumier</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>A</given-names></name><name><surname>Hoover</surname><given-names>JJ</given-names></name><article-title>Vitamin measurements in pooled blood samples</article-title><source>Am J Epidemiol</source><year>1986</year><volume>123</volume><issue>3</issue><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">3946400</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Caudill</surname><given-names>SP</given-names></name><article-title>Important issues related to using pooled samples for environmental chemical biomonitoring</article-title><source>Stat Med</source><year>2011</year><volume>30</volume><issue>5</issue><fpage>515</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/sim.3885</pub-id><pub-id pub-id-type="pmid">21312217</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Schisterman</surname><given-names>EF</given-names></name><name><surname>Perkins</surname><given-names>NJ</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Bondell</surname><given-names>H</given-names></name><article-title>Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples</article-title><source>Epidemiology</source><year>2005</year><volume>16</volume><issue>1</issue><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1097/01.ede.0000147512.81966.ba</pub-id><pub-id pub-id-type="pmid">15613948</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Caudill</surname><given-names>SP</given-names></name><article-title>Characterizing populations of individuals using pooled samples</article-title><source>J Expo Sci Environ Epidemiol</source><year>2010</year><volume>20</volume><issue>1</issue><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/jes.2008.72</pub-id><pub-id pub-id-type="pmid">19002216</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Voigt</surname><given-names>K</given-names></name><name><surname>Bruggemann</surname><given-names>R</given-names></name><name><surname>Scherb</surname><given-names>H</given-names></name><name><surname>Cok</surname><given-names>I</given-names></name><name><surname>Mazmanci</surname><given-names>B</given-names></name><name><surname>Mazmanci</surname><given-names>MA</given-names></name><name><surname>Turgut</surname><given-names>C</given-names></name><name><surname>Schramm</surname><given-names>K-W</given-names></name><article-title>Evaluation of organochlorine pesticides in breast milk samples in Turkey applying features of the partial order technique</article-title><source>Int J Environ Health Res</source><year>2013</year><volume>23</volume><issue>3</issue><fpage>226</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1080/09603123.2012.717915</pub-id><pub-id pub-id-type="pmid">22963053</pub-id></mixed-citation></ref></ref-list></back></article>